mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.077 |
0.1 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
BIRB 0796 |
FIMM |
pan-cancer |
AAC |
0.28 |
0.1 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.25 |
0.1 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |